Evidence map›Paper›PMID 41184876›Full record

ArticleBMC cancer2025

Protocol for Fit4Transplant: iterative optimisation of an exercise prehabilitation service for haematological cancer patients using phase II adaptive trials and co-design.

Camille E Short, Lara Edbrooke, Shaza Abo, Tamara Jones, Amit Khot, Robert K Mahar, Jasmyne Lee, Jess Crowe, Sarah Stratulate, Catherine L Granger and 2 more

Abstract read
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Camille E ShortMelbourne Centre for Behaviour Change, Melbourne School of Psychological Sciences, The University of Melbourne, Melbourne, Australia. camille.short@unimelb.edu.au.
Lara EdbrookeDepartment of Physiotherapy, Melbourne School of Health Sciences, The University of Melbourne, Melbourne, Australia.
Shaza AboDepartment of Physiotherapy, Melbourne School of Health Sciences, The University of Melbourne, Melbourne, Australia.
Tamara JonesMelbourne Centre for Behaviour Change, Melbourne School of Psychological Sciences, The University of Melbourne, Melbourne, Australia.
Amit KhotDepartment of Oncology, University of Melbourne, Parkville, Australia.
Robert K MaharBiostatistics Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia.
Jasmyne LeePhysiotherapy Department, Peter MacCallum Cancer Centre, Melbourne, Australia.
Jess CrowePhysiotherapy Department, Peter MacCallum Cancer Centre, Melbourne, Australia.
Sarah StratulateDepartment of Physiotherapy, Melbourne School of Health Sciences, The University of Melbourne, Melbourne, Australia.
Catherine L GrangerDepartment of Physiotherapy, Melbourne School of Health Sciences, The University of Melbourne, Melbourne, Australia.
Selina M ParryDepartment of Physiotherapy, Melbourne School of Health Sciences, The University of Melbourne, Melbourne, Australia.
Linda DenehyDepartment of Physiotherapy, Melbourne School of Health Sciences, The University of Melbourne, Melbourne, Australia.

Funding

Victorian Cancer Agency MCRF19028
6 · The paper itself

Abstract

backgroundHematopoietic stem cell transplantation is a critical intensive treatment option for many people with haematological cancer but often leads to long-term reductions in physical function. Exercise-based prehabilitation can help to mitigate these effects and improve wellbeing. This study aims to evaluate and iteratively refine co-designed enhancements to an existing exercise-prehabilitation service.

methodTwo intervention packages will be evaluated in sequential single-arm Bayesian optimal phase II adaptive trials. Package 1 will include two staff training modules (focused on trauma-informed service delivery and delivering engaging exercise classes online) and a behaviour Change booklet for patients. Package 2 will include refined (if necessary) Package 1 components, as well as an interactive self-management website/mobile application for patients. Outcome assessments will be conducted at baseline and post-intervention. The rate of promising response (a composite efficacy and acceptability outcome) in each trial will be monitored with interim analyses after 30 participants have completed post-intervention assessments. The intervention will be ceased prior to reaching the recruitment target (n = 60) if inadequate promising responses are observed (≥ 11 participants not meeting promising response criteria). A sub-sample of participants will also be invited to participate in an interview regarding stakeholder experiences delivering and receiving the intervention packages. Recruitment will commence in February 2025. DISCUSSION: This sequential adaptive design allows trialling a simpler intervention while the digital component is finalised, with iterative refinements guided by interim analyses and co-design. The outcomes of this study will help inform future prehabilitation programs involving exercise programs and provide an example of how co-design and adaptive trials can be combined to optimise behavioural health interventions within routine care.

trial registrationAustralian NewZealand Clinical Trial Registry ACTRN12624000363583p. Registered 28th March 2024.

Indexed as

Exercise TherapyHematologic NeoplasmsHematopoietic Stem Cell TransplantationPreoperative ExerciseAdaptive Clinical Trials as TopicBayes TheoremFemaleHumansResearch DesignBehaviour changeCancerDigitalExerciseOncologyPhysical activity

Identifiers

PMID41184876
PMCPMC12581277

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.